Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AF Direct factor Xa inhibitors
B01AF03 Edoxaban
D09546 Edoxaban tosilate hydrate (JAN) <JP/US>
USP drug classification [BR:br08302]
Blood Products and Modifiers
Anticoagulants
Factor Xa Inhibitors, Direct
Edoxaban
D09546 Edoxaban tosilate hydrate (JAN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
33 Blood and body fluid agents
333 Anticoagulants
3339 Others
D09546 Edoxaban tosilate hydrate (JAN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01662 Factor Xa inhibitor
DG01398 Edoxaban
D09546 Edoxaban tosilate hydrate
Transporter substrate
DG01665 ABCB1 substrate
DG01398 Edoxaban
D09546 Edoxaban tosilate hydrate
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Serine peptidases
F10
D09546 Edoxaban tosilate hydrate (JAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09546
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09546
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09546
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09546
Drug metabolizing enzymes and transporters [br08309.html]
Drug transporters
D09546
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01662 Factor Xa inhibitor
DG01398 Edoxaban
Transporter substrate
DG01665 ABCB1 substrate
DG01398 Edoxaban